
Overview
Gary D. Hammer, M.D., Ph.D. is Professor in Departments of InternalMedicine (MEND), Cell & Developmental Biology, and Molecular &Integrative Physiology. He currently serves as Director of EndocrineOncology Program in Rogel Cancer Center where he holds the MillieSchembechler Professorship in Adrenal Cancer. He is past Director ofCenter for Organogenesis: Stem Cells & Regenerative Medicine. He hasbrokered the recent renaissance of the current Michigan team of adrenalscientists that includes a who’s who in the study of adrenal disease.He received the UofM Jerome Conn Award for Outstanding Research inInternal Medicine, the Endocrine Society Edwin B. Astwood Award forOutstanding Research and is a member of ASCI and AAP. He has served innumerous leadership roles at UofM and in the public and private sectorsincluding recent tenure on Board of Scientific Advisors for NCI. He isthe editor of four textbooks including Pathophysiology of Disease: AnIntroduction to Clinical Medicine (McGraw Hilll), and the upcomingAdrenal Section Editor for Degroot’s Endocrinology (Elsevier). He hasserved in numerous capacities for the world’s largest endocrineorganization, the Endocrine Society including his most recent role asPresident of the Society (2020-2021). An Advisor to the CongressionalH.E.L.P. committee - he co-authored the 21st Century Cancer ALERT(Access to Life-Saving Early detection, Research and Treatment) Act’’ lintroduced in Congress in 2009. He has been catalyst for the formationof two international cooperative groups, most recently the A5 (AmericanAustralian Asian Adrenal Alliance) that leverages collaboration tosecure projects from Pharma and funding agencies across the spectrum ofadrenal diseases. He is a cofounder of two companies - MILLENDO andSLING THERAPEUTICS that focus on rare endocrine diseases.
Dr. Hammer is highly rated in 13 conditions, according to our data. His top areas of expertise are Adrenal Cancer, Adrenocortical Carcinoma, Neuroblastoma, and Hereditary Neuroblastoma.
His clinical research consists of co-authoring 85 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Graduate Institution
Residency
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- HMO
- POS
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1500 E Medical Center Dr, Floor B1 Reception A, Ann Arbor, MI 48109
Additional Areas of Focus
Dr. Hammer has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Domino's Farms
Dr. Richard Auchus is a professor of Internal Medicine, Division of Metabolism, Endocrinology & Diabetes (MEND) and Chief of the Endocrinology & Metabolism Section at the Ann Arbor VA Medical Center. He received his medical degree and Ph.D. in pharmacology from Washington University in St. Louis. Then Dr. Auchus completed a residency at the University of Iowa and an endocrinology fellowship at UTHSC-San Antonio/Wilford Hall Medical Center. Dr. Auchus came to UMHS from the Graduate School of Biomedical Sciences in Southwestern Medical School, University of Texas, where he was a Professor of Internal Medicine - Endocrinology.Dr. Auchus is a steroid biologist with expertise both in basic science and clinical/translational science. His work has included translational research into: molecular and genetic mechanisms of human hypertension, improved diagnostic studies and management in primary aldosteronism and Cushing syndromes, modifier genes in 21-hydroxylase deficiency, cardiovascular disease in polycystic ovary syndrome, and the endocrinology of traumatic brain injury. Dr. Auchus is highly rated in 20 conditions, according to our data. His top areas of expertise are Congenital Adrenal Hyperplasia (CAH), Intersex, Cushing's syndrome, Hormone Replacement Therapy (HRT), and Orchiectomy.
Rogel Cancer Center
Dr. Else’s primary appointment is with the Division of Metabolism, Endocrinology and Diabetes. He received his MD degree from the University of Hamburg, Germany. He pursued his clinical training at the University of Hamburg (Residency: Internal Medicine) and the University of Michigan (Residency: Internal Medicine, Fellowship: Endocrinology). His main research interests are the genetics of endocrine tumors. Dr. Else’s clinical practice focuses on the care for patients with benign and malignant endocrine tumors, particularly pheochromocytoma, adrenocortical tumors and neuroendocrine tumors as well as accompanying hormone excess syndromes (e.g Cushing syndrome, primary aldosteronism). Dr. Else has a particular interest in taking care of patients with hereditary syndromes that predispose to the development of endocrine tumors (e.g. Multiple Endocrine Neoplasia (MEN) type 1, MEN2A & MEN2B, Hereditary Paraganglioma Syndrome). He attends the Multidisciplinary Endocrine Oncology Clinic, where patients with tumors receive diagnostic procedures and treatment. In addition he is part of the Cancer Genetics Clinic, which evaluates patients for hereditary syndromes and also facilitates regular exams and surveillance for patients at risk for endocrine tumors. Dr. Else is highly rated in 105 conditions, according to our data. His top areas of expertise are Adrenal Cancer, Adrenocortical Carcinoma, Adrenal Gland Adenoma, Neuroendocrine Tumor, and Thyroidectomy.
Rogel Cancer Center
Dr. Adina Turcu completed her Internal Medicine residency at Norwalk Hospital/Yale University, CT, where she also served a year as Chief Resident. She completed her Endocrinology fellowship at Mayo Clinic, Rochester, MN, where she was the recipient of the Randall G. Sprague Award for outstanding clinical, investigative, and academic achievement in Endocrinology.Dr. Turcu pursued a postdoctoral fellowship at the University of Michigan, prior to joining the UoM faculty team in the Division of Metabolism, Endocrinology & Diabetes. Her research work focuses on adrenal disorders, including congenital adrenal hyperplasia, Cushing’s syndrome, primary aldosteronism, and pheochromocytoma/paraganglioma. Dr. Turcu is highly rated in 23 conditions, according to our data. Her top areas of expertise are Hyperaldosteronism, Congenital Adrenal Hyperplasia (CAH), Adrenal Gland Adenoma, Intersex, and Hormone Replacement Therapy (HRT).
Frequently Asked Questions about Dr. Gary D. Hammer
How do I make an appointment with Dr. Gary D. Hammer?
You can book an appointment with Dr. Gary D. Hammer by calling their office at 734-647-8902. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Gary D. Hammer a top-rated expert for Adrenal Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Gary D. Hammer is classified as an Elite expert for Adrenal Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Gary D. Hammer specialize in?
While Dr. Gary D. Hammer is a Endocrinology, they have specific expertise in Adrenal Cancer, Adrenocortical Carcinoma, and Neuroblastoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Endocrinology.
Does Dr. Gary D. Hammer participate in research or clinical trials?
Yes. Dr. Gary D. Hammer has published 83 articles and abstracts on conditions like Adrenal Cancer. You can view a list of Dr. Gary D. Hammer's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Gary D. Hammer accept my insurance?
Dr. Gary D. Hammer accepts most major insurance plans, including Blue Cross Blue Shield and Cigna. We recommend calling the office directly at 734-647-8902 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Adrenal CancerDr. Hammer isElite. Learn about Adrenal Cancer.
- Adrenocortical CarcinomaDr. Hammer isElite. Learn about Adrenocortical Carcinoma.
- Distinguished
- Familial Glucocorticoid DeficiencyDr. Hammer isDistinguished. Learn about Familial Glucocorticoid Deficiency.
- Hereditary NeuroblastomaDr. Hammer isDistinguished. Learn about Hereditary Neuroblastoma.
- NeuroblastomaDr. Hammer isDistinguished. Learn about Neuroblastoma.
- Advanced
- Addison's DiseaseDr. Hammer isAdvanced. Learn about Addison's Disease.
- Adrenal Gland AdenomaDr. Hammer isAdvanced. Learn about Adrenal Gland Adenoma.
- Adrenal Insufficiency PediatricDr. Hammer isAdvanced. Learn about Adrenal Insufficiency Pediatric.
- Cushing's syndromeDr. Hammer isAdvanced. Learn about Cushing's syndrome.
- Cushing's syndrome due to Adrenal Tumor
- Exogenous Cushing's syndromeDr. Hammer isAdvanced. Learn about Exogenous Cushing's syndrome.
- Experienced
- Anaplastic Thyroid CancerDr. Hammer isExperienced. Learn about Anaplastic Thyroid Cancer.
- Congenital Adrenal Hyperplasia (CAH)Dr. Hammer isExperienced. Learn about Congenital Adrenal Hyperplasia (CAH).
- Cushing's diseaseDr. Hammer isExperienced. Learn about Cushing's disease.
- Ectopic Cushing's syndromeDr. Hammer isExperienced. Learn about Ectopic Cushing's syndrome.
- Follicular Thyroid CancerDr. Hammer isExperienced. Learn about Follicular Thyroid Cancer.
- Graves DiseaseDr. Hammer isExperienced. Learn about Graves Disease.

